Johnson Matthey (LON:JMAT – Get Free Report)‘s stock had its “restricted” rating reissued by Jefferies Financial Group in a research note issued on Friday,London Stock Exchange reports.
Several other analysts also recently weighed in on the company. Berenberg Bank decreased their target price on Johnson Matthey from GBX 2,250 to GBX 2,100 and set a “buy” rating for the company in a research note on Monday, March 23rd. Deutsche Bank Aktiengesellschaft lifted their price target on Johnson Matthey from GBX 1,922 to GBX 2,120 and gave the stock a “buy” rating in a research report on Tuesday, April 7th. Finally, UBS Group reissued a “neutral” rating and issued a GBX 2,200 price objective on shares of Johnson Matthey in a research report on Friday, May 22nd. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 2,218.33.
Check Out Our Latest Analysis on Johnson Matthey
Johnson Matthey Stock Performance
Johnson Matthey (LON:JMAT – Get Free Report) last released its quarterly earnings results on Thursday, May 28th. The company reported GBX 128.50 earnings per share (EPS) for the quarter. The company had revenue of GBX 1,257.30 billion during the quarter. Johnson Matthey had a negative net margin of 1.13% and a negative return on equity of 5.87%. On average, equities research analysts forecast that Johnson Matthey will post 173.4112903 EPS for the current fiscal year.
Insider Buying and Selling
In other news, insider Liam Condon acquired 14 shares of the firm’s stock in a transaction dated Wednesday, March 11th. The shares were bought at an average price of GBX 1,941 per share, with a total value of £271.74. Also, insider Alastair Judge acquired 14 shares of the stock in a transaction dated Wednesday, April 15th. The shares were purchased at an average price of GBX 2,022 per share, for a total transaction of £283.08. Insiders acquired a total of 72 shares of company stock valued at $146,198 in the last quarter. Corporate insiders own 0.51% of the company’s stock.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Further Reading
- Five stocks we like better than Johnson Matthey
- Palomar’s High-Risk Insurance Strategy Is Paying Off Big
- Marvell’s Pullback May Be the Setup Bulls Were Waiting For
- Flight Path to Profits: American Airlines Bets on SpaceX
- Wall Street Is Starting to Talk About Tesla’s Endgame
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
